Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib

NCT01540526 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Solid Malignancies
Metastatic Castrate-resistant Prostate Cancer

Interventions

DRUG: axitinib

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]